GLOW Blend has been examined in preclinical in vitro and rodent model studies of angiogenesis, collagen and extracellular matrix synthesis, cell migration, inflammatory signaling, and wound-healing dynamics. Its combined formulation supports comparative and additive-effect research across the tissue-repair pathways associated with its constituent peptides in cell-based and rodent models.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides GLOW Blend appeared first on PrecisionsPeptides.com.

SS-31 has been used in preclinical in vitro and rodent model studies to investigate mitochondrial membrane integrity, electron transport efficiency, reactive oxygen species production, and cellular energy metabolism under stress conditions. Its cardiolipin affinity supports mechanistic characterization of mitochondrial biology in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides SS-31 appeared first on PrecisionsPeptides.com.

This combination has been examined in preclinical in vitro and rodent model studies of pituitary GH secretion dynamics, the additive effects of GHRH and GHSR pathway activation, IGF-1 axis modulation, and pulsatile GH release characterization. The dual-pathway formulation supports comparative mechanistic studies of the GH axis in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides CJC-1295 (No DAC) + Ipamorelin appeared first on PrecisionsPeptides.com.

AOD-9604 has been examined in preclinical in vitro and rodent model studies of lipolysis, adipocyte metabolism, lipid oxidation pathways, and energy-balance endpoints. Its fragment structure supports mechanistic characterization of GH-related metabolic signaling in cell-based and rodent research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides AOD-9604 appeared first on PrecisionsPeptides.com.

Oxytocin has been used in preclinical in vitro and rodent model studies to investigate receptor signaling dynamics, social and pair-bonding behavioral paradigms, stress-axis modulation, smooth muscle contractility, and neuroendocrine release characterization. Its established pharmacology supports a broad range of cell-based and rodent research applications.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides Oxytocin appeared first on PrecisionsPeptides.com.

PT-141 has been used in preclinical in vitro and rodent model studies to investigate melanocortin receptor signaling, central nervous system-mediated behavioral paradigms, neuroendocrine response characterization, and downstream second-messenger activity. Its defined receptor profile supports mechanistic studies of the melanocortin system in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides PT-141 appeared first on PrecisionsPeptides.com.

Melanotan 1 has been used in preclinical in vitro and rodent model studies to investigate melanogenesis, melanocortin-1 receptor signaling, photoprotective cellular responses, and oxidative stress pathways in melanocyte cultures. Its receptor selectivity supports mechanistic characterization of pigmentation biology in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides Melanotan 1 appeared first on PrecisionsPeptides.com.

Melanotan 2 has been used in preclinical in vitro and rodent model studies to investigate melanogenesis, melanocortin receptor signaling, appetite and energy-balance behavioral paradigms, and downstream second-messenger activity. Its broad receptor activity supports comparative mechanistic studies of the melanocortin system in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides Melanotan 2 appeared first on PrecisionsPeptides.com.

KLOW Blend has been examined in preclinical in vitro and rodent model studies of angiogenesis, extracellular matrix synthesis, cell migration, inflammatory cytokine and NF-kB signaling, and wound-healing dynamics. Its combined formulation supports comparative and additive-effect research across the tissue-repair and anti-inflammatory pathways associated with its constituent peptides in cell-based and rodent models.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides KLOW Blend appeared first on PrecisionsPeptides.com.

GHK-Cu has been used in preclinical in vitro and rodent model studies to investigate collagen and extracellular matrix synthesis, angiogenesis, antioxidant gene expression, and wound-healing dynamics. Its copper-peptide chemistry supports mechanistic studies of tissue remodeling and gene regulation in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides GHK-Cu appeared first on PrecisionsPeptides.com.